NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 283 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,230 | -23.5% | 100 | 0.0% | 0.00% | – |
| Q2 2023 | $1,607 | -7.7% | 100 | 0.0% | 0.00% | – |
| Q1 2023 | $1,741 | +88.4% | 100 | 0.0% | 0.00% | – |
| Q4 2022 | $924 | -7.6% | 100 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 100 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $3,000 | -40.0% | 100 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $5,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $5,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | -54.5% | 100 | -50.0% | 0.00% | -50.0% |
| Q4 2020 | $11,000 | +37.5% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $8,000 | +14.3% | 200 | 0.0% | 0.00% | +33.3% |
| Q2 2020 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | -25.0% |
| Q1 2020 | $6,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,612,363 | $55,014,000 | 24.06% |
| PERKINS CAPITAL MANAGEMENT INC | 155,550 | $5,307,000 | 3.58% |
| First Light Asset Management, LLC | 763,907 | $26,065,000 | 1.87% |
| Bullseye Asset Management LLC | 108,054 | $3,617,000 | 1.44% |
| Ranger Investment Management | 756,380 | $25,808,000 | 1.41% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,006,088 | $34,328,000 | 1.21% |
| EMERALD ADVISERS, LLC | 885,436 | $30,211,000 | 1.12% |
| Granite Investment Partners, LLC | 963,187 | $32,864,000 | 0.96% |
| Nicholas Investment Partners, LP | 428,378 | $14,616,000 | 0.92% |
| Redwood Investments, LLC | 335,054 | $11,432,000 | 0.90% |